![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/27/2905200/0/en/Oragenics-Develops-Automated-Intranasal-Device-for-Treating-Concussed-Patients.html
https://www.globenewswire.com/news-release/2024/06/26/2904834/0/en/Oragenics-Inc-Announces-Closing-of-Public-Offering.html
https://www.globenewswire.com/news-release/2024/06/25/2903773/0/en/Oragenics-Inc-Announces-Pricing-of-Public-Offering.html
https://www.globenewswire.com/news-release/2024/06/24/2903436/0/en/Oragenics-Inc-Announces-Proposed-Public-Offering.html
https://www.globenewswire.com/news-release/2024/06/20/2901627/0/en/Oragenics-Inc-Announces-NYSE-American-Acceptance-of-Plan-of-Compliance.html
https://www.globenewswire.com/news-release/2024/05/22/2886409/0/en/Oragenics-Appoints-William-Frank-Peacock-MD-as-Chief-Clinical-Officer.html
https://www.globenewswire.com/news-release/2024/05/17/2884192/0/en/Oragenics-Inc-to-Host-Webinar-Panel-on-Neurotrauma-Medicine.html
https://www.globenewswire.com/news-release/2024/05/16/2883360/0/en/Oragenics-Inc-Prepares-Intranasal-Pharmaceutical-ONP-002-for-Phase-II-Concussion-Trial.html
https://www.globenewswire.com/news-release/2024/05/07/2876669/0/en/Oragenics-Partners-with-Avance-Clinical-for-Phase-II-Concussion-Trial-in-Australia.html